Bellevue Asset Management »

Aytu Biopharma shares owned by Bellevue Asset Management

Quarter-by-quarter ownership of Aytu Biopharma (AYTU) shares owned by Bellevue Asset Management from 13F filings

Historical chart of Bellevue Asset Management investment in Aytu Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Aytu Biopharma held by Bellevue Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aytu Biopharma by Bellevue Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $65k 25k 2.60

More positions owned by Bellevue Asset Management

First Tr Exchange-traded Risng Divd Achiv (RDVY)
Microsoft Corporation (MSFT)
Apple (AAPL)
Capital Group Growth Etf Shs Creation Uni (CGGR)
First Tr Exchange- Traded Fst Low Oppt Etf (LMBS)
Amazon (AMZN)
Costco Wholesale Corporation (COST)
Jp Morgan Exchange Traded F Intrnl Res Eqt (JIRE)
Blackrock Etf Trust Ishares Us Equit (DYNF)
Vanguard World Inf Tech Etf (VGT)
Tcw Etf Trust Flexible Income (FLXR)
Jp Morgan Exchange Traded F Short Dura Core (JSCP)
First Tr Exchange-traded First Tr Enh New (FTSM)
Starbucks Corporation (SBUX)
Jp Morgan Exchange Traded F Equity Premium (JEPI)

View all positions for Bellevue Asset Management

Top funds holding Aytu Biopharma

Nantahala Capital Management
Stonepine Capital Management
AWM Investment Company
Vanguard Group
Diadema Partners
Renaissance Technologies
Geode Capital Management
Two Sigma Investments
Persistent Asset Partners
Two Sigma Advisers
FNY Investment Advisers
Dimensional Fund Advisors
Bellevue Asset Management
BlackRock
Acadian Asset Management

View all funds holding Aytu Biopharma